"Weak" margins weigh on J&J's fourth quarter and full year
This article was originally published in Clinica
Executive Summary
Weak margins have impacted Johnson & Johnson's 2011 financial results for the second consecutive quarter, as its bottom line took a hit from one-off charges relating to recalls and litigation. Although fourth-quarter revenues were in line with consensus analyst estimates, the firm's operating income fell 15% short of predictions by Morgan Stanley analyst David Lewis.